127 related articles for article (PubMed ID: 15088180)
1. [Comparison of different MRI sequences with and without application of Gd-BOPTA as follow-up after LITT].
Pech M; Spors B; Wieners G; Warschewske G; Beck A; Cho C; Fischbach F; Ricke J
Rofo; 2004 Apr; 176(4):550-5. PubMed ID: 15088180
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
Zhang HM; Ouyang H; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
[TBL] [Abstract][Full Text] [Related]
3. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
5. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N
Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
[TBL] [Abstract][Full Text] [Related]
7. Double contrast MRI of thermally ablated liver metastases.
Puls R; Kröncke TJ; Klüner C; Gaffke G; Stroszczynski C; Albrecht T; Speck U; Hamm B
Rofo; 2003 Nov; 175(11):1467-70. PubMed ID: 14610696
[TBL] [Abstract][Full Text] [Related]
8. [Laser-induced thermotherapy of liver metastases with MRI control. Prospective results of an optimized therapy procedure].
Vogl TJ; Müller P; Hirsch H; Philipp C; Hammerstingl R; Böttcher H; Riess H; Beuthan J; Felix R
Radiologe; 1995 Mar; 35(3):188-99. PubMed ID: 7761595
[TBL] [Abstract][Full Text] [Related]
9. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
10. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application.
Caudana R; Morana G; Pirovano GP; Nicoli N; Portuese A; Spinazzi A; Di Rito R; Pistolesi GF
Radiology; 1996 May; 199(2):513-20. PubMed ID: 8668804
[TBL] [Abstract][Full Text] [Related]
11. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla.
Bueltmann E; Erb G; Kirchin MA; Klose U; Naegele T
Invest Radiol; 2008 Oct; 43(10):695-702. PubMed ID: 18791411
[TBL] [Abstract][Full Text] [Related]
12. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis.
Akpinar E; Turkbey B; Karcaaltincaba M; Balli O; Akkapulu N; Balas S; Tirnaksiz B; Akata D; Akhan O
J Magn Reson Imaging; 2009 Sep; 30(3):578-85. PubMed ID: 19711404
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
[TBL] [Abstract][Full Text] [Related]
14. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
[TBL] [Abstract][Full Text] [Related]
15. High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis.
Bremer C; Bankert J; Filler T; Ebert W; Tombach B; Reimer P
J Magn Reson Imaging; 2005 Jun; 21(6):801-8. PubMed ID: 15906334
[TBL] [Abstract][Full Text] [Related]
16. Hepatic transit time analysis using contrast enhanced MRI with Gd-BOPTA: A prospective study comparing patients with liver metastases from colorectal cancer and healthy volunteers.
Hohmann J; Newerla C; Müller A; Reinicke C; Skrok J; Frericks BB; Albrecht T
J Magn Reson Imaging; 2012 Dec; 36(6):1389-94. PubMed ID: 22893441
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of necrosis after laser-induced thermotherapy in contrast-enhanced MRI and implications for treatment success].
Kühn JP; Puls R; Wallaschowski H; Heidecke CD; Rosenberg C; Hosten N
Rofo; 2008 Sep; 180(9):816-20. PubMed ID: 18671194
[TBL] [Abstract][Full Text] [Related]
18. Continuously moving table MRI with sliding multislice for rectal cancer staging: image quality and lesion detection.
Baumann T; Ludwig U; Pache G; Fautz HP; Kotter E; Langer M; Schaefer O
Eur J Radiol; 2010 Mar; 73(3):579-87. PubMed ID: 19179029
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of CNS tumors: are all contrast agents created the same?
Essig M
Neuroradiology; 2006 Apr; 48 Suppl 1():3-8. PubMed ID: 16699847
[TBL] [Abstract][Full Text] [Related]
20. Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths.
Yrjänä SK; Vaara T; Karttunen A; Koivukangas J
Invest Radiol; 2008 Apr; 43(4):267-75. PubMed ID: 18340251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]